Companies × risks
Novo Nordisk
Novo Nordisk deploys third-party GenAI at enterprise scale through an AWS Bedrock-based platform used by over 25,000 employees across 2,500+ chatbot use cases, and uses Azure OpenAI for R&D workflows. It also develops specialised AI models for drug discovery, cardiovascular risk prediction, and biomedical applications.
We reviewed 3 public documents from Novo Nordisk and found it acknowledges 1 of 24 AI risks: discrimination.
Sector: Agriculture, Mining, Construction and Manufacturing; Chemicals & pharmaceutical manufacturing
Roles: AI deployer
AI risks Novo Nordisk acknowledges
- Discrimination: “Developers and owners should strive to minimize bias and maximize fairness in AI systems... evaluate if those assumptions minimize any bias of the developer or a bias that is present in the data” (Data ethics | Novo Nordisk data ethics principles)
Documents we reviewed
- Data ethics | Novo Nordisk data ethics principles (AI overview & principles, 2026)
- Novonordisk - 2024 Form 20-F Annual Report (Annual report, 2025)
- Novo Nordisk Annual Report 2025 (Annual report, 2026)